Quick Answer
MOLECULAR PARTNERS AG reported Total Assets of $102.11 million for fiscal year 2025.
MOLECULAR PARTNERS AG — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $102.11M -35.6% |
$158.53M -20.1% |
$198.35M -24.4% |
$262.26M +51.9% |
$172.67M -7.9% |
$187.55M |
| R&D Expense | $40.19M -17.3% |
$48.60M -0.4% |
$48.78M -3.9% |
$50.75M -8.9% |
$55.72M -0.6% |
$56.08M +28.9% |
- MOLECULAR PARTNERS AG reported Total Assets of $102.11 million for fiscal year 2025.
- MOLECULAR PARTNERS AG showed a decrease of -35.6% in Total Assets compared to the prior fiscal year.
- MOLECULAR PARTNERS AG reported R&D Expense of $40.19 million for fiscal year 2025.
- MOLECULAR PARTNERS AG showed a decrease of -17.3% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: